• Rescuing a Study in Jeopardy with Comprehensive Clinical Adjudication

    Clinical Research News | Global clinical trial programs are complex, often encompassing dozens of studies for increasingly uncommon indications. Sponsors of these programs are wisely seeking out independent adjudication of clinical events, or endpoints, that occur over the course of the trial to ensure patient safety and the efficacy of drugs and devices. While endpoint adjudication is not required by regulatory bodies, it can deliver valuable insights during a trial and lend strong, unbiased support for approvals down the road.

    Jun 16, 2023

  • N-Lorem Foundation Bringing Real Hope To ‘N-Of-1’ Patients

    Clinical Research News | Stanley T. Crooke, M.D., Ph.D., founder and longtime leader of the company that pioneered RNA-targeted therapeutics, is now chairman and CEO of the n-Lorem Foundation descaling the technology to treat patients helpless before a healthcare system that wasn’t built for “n-of-1” problems. He will be addressing a room of physicians and scientists tomorrow on the campus of Vanderbilt University.

    Jun 14, 2023

  • Novo Nordisk Home-Grows Group To Digitalize Early Clinical Research

    Clinical Research News | Novo Nordisk launched a digital science and innovation group early in 2022 with the intention of digitalizing clinical research activities, mirroring the way the commercial side of the house has been operating for years. Novo Nordisk has embedded the group within the research organization rather than created a separate product or short-lived initiative.

    Jun 14, 2023